Botulinum Toxin Type A and Divalproex Sodium for Prophylactic Treatment of Episodic or Chronic Migraine von Blumenfeld, Andrew M., Schim, Jack D., Chippendale, Thomas J.

Volltext

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized... von Schim, Jack D., Anderson, Carlton, Brunner, Elizabeth, Hirman, Joe, Ogbru, Annette, Cady, Roger, McGill, Lora

Volltext

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review von Blumenfeld, Andrew M., Frishberg, Benjamin M., Schim, Jack D., Iannone, Ashley, Schneider, Gary, Yedigarova, Larisa, Manack Adams, Aubrey

Volltext

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial von Aurora, SK, Dodick, DW, Turkel, CC, DeGryse, RE, Silberstein, SD, Lipton, RB, Diener, HC, Brin, MF

Volltext

Real-World Evidence for Control of Chronic Migraine (CM) in Patients Meeting American Headache Society (AHS) Criteria Who Received Calcitonin Gene–Related Peptide Monoclonal Antibo... von Blumenfeld, Andrew M., Frishberg, Benjamin M., Schim, Jack D., Iannone, Ashley, Yedigarova, Larisa, Adams, Aubrey Manack

Volltext

Real-World Evidence for Control of Patients With Chronic Migraine Who Received Calcitonin Gene–Related Peptide (CGRP) Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatm... von Blumenfeld, Andrew M., Frishberg, Benjamin M., Schim, Jack D., Iannone, Ashley, Yedigarova, Larisa, Adams, Aubrey Manack

Volltext

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial von Diener, HC, Dodick, DW, Aurora, SK, Turkel, CC, DeGryse, RE, Lipton, RB, Silberstein, SD, Brin, MF

Volltext

Overview of Pain Management von Schim, Jack D., Stang, Paul

Volltext

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review von Adis journalson behalf of, Blumenfeld, Andrew M, Frishberg, Benjamin M, Schim, Jack D, Iannone, Ashley, Schneider, Gary, Yedigarova, Larisa, Adams, Aubrey Manack

Volltext bestellen

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of ‘off’ episodes in patients with Parkinson's disease... von Lew, Mark F., Pahwa, Rajesh, Leehey, Maureen, Bertoni, John, Kricorian, Greg

Volltext

Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches - A Narrative Review von Blumenfeld, Andrew, Ashkenazi, Avi, Napchan, Uri, Bender, Steven D., Klein, Brad C., Berliner, Randall, Ailani, Jessica, Schim, Jack, Friedman, Deborah I., Charleston IV, Larry, Young, William B., Robertson, Carrie E., Dodick, David W., Silberstein, Stephen D., Robbins, Matthew S.

Volltext

Probabilité de réponse à l’administration suivante chez les patients souffrant de migraine et présentant une réponse initiale sous-optimale avec eptinezumab von Schim, Jack, Anderson, Carlton, Brunner, Elizabeth, Ogbru, Annette, Cady, Roger, Mcgill, Lora, Defawe Rajca, Caroline

Volltext